• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Post-Wonderland Debrief: Wake Network

Microdose by Microdose
November 23, 2021
in Events
Reading Time: 2 mins read
A A
Post-Wonderland Debrief: Wake Network

Running from November 8-9, 2021 in Miami, Wonderland was an impressive collection of scientists and researchers, investors and entrepreneurs, therapists and patients, government officials, and media — all championing the growth of the psychedelic medicine industry.

From heavyweight celebrities like Mike Tyson, to the industry’s top companies and insiders, Wonderland was the sector’s largest in-person event. The psychedelic medicine industry has officially arrived and we’re proud to be a part of it.

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry.

Here’s a summary of Platinum Sponsor Wake Network and their participation at Wonderland.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

In addition to their generous financial support, Wake Network also participated in an important industry panel:

Continue on your trip...

Wonderland 2023 Review: PsychMD

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

The World on Drugs: Documentary Premiere at Wonderland

“Precision Medicine and Psychedelics”

About the panel: Olga Chernoloz, PhD, Chief Scientific Officer for Wake Network gave an informative presentation, asking and answering questions like:

1. Are psychedelics a panacea and what does blood have to do with it?

2. What is precision medicine and why does it matter?

3. Our genetics don’t tell the full picture.

4. Flamingos are instagram worthy.

Lasix at Discount Price

5. Pharmacometabolomics.

6. How Wake will precision guide psychedelics for you.

Dr. Olga Chernoloz, Wake Network
Dr. Olga Chernoloz, Chief Scientific Officer for Wake Network

Olga Chernoloz, PhD, Chief Scientific Officer

[bsa_pro_ad_space id=2]
ADVERTISEMENT

With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr. Chernoloz, leads R&D programs, runs feasibility analyses and optimizes business development strategy taking into consideration scientific and regulatory underpinnings. She has developed and delivered educational modules for medical and adult psychedelic space in both academic and business settings.

About the sponsor:

Wake Network is a vertically integrated fungi medicine company focused on addressing the most critical mental health challenges facing the world today and tomorrow. The Wake Network’s industry leading cultivation and approach to novel clinical research with fungus based substances is all backed by their compliance focused virtual wellness platform. The Wake Network is a decentralized international fungus company with operating facilities in Canada, Jamaica and the USA.

Tags: Wake Network
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post

Post-Wonderland Debrief: Numinus Wellness

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.